These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27550408)

  • 1. Distal pancreatectomy with splenectomy for the management of splenic hilum metastasis in cytoreductive surgery of epithelial ovarian cancer.
    Xiang L; Tu Y; He T; Shen X; Li Z; Wu X; Yang H
    J Gynecol Oncol; 2016 Nov; 27(6):e62. PubMed ID: 27550408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Splenectomy in epithelial ovarian cancer: analysis of 32 cases].
    Zheng AW; Zheng F; Chen YQ; Zhu HN; Qian JH
    Zhonghua Fu Chan Ke Za Zhi; 2008 Mar; 43(3):197-200. PubMed ID: 18788569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The feasibility and morbidity of distal pancreatectomy in extensive cytoreductive surgery for advanced epithelial ovarian cancer.
    Yildirim Y; Sanci M
    Arch Gynecol Obstet; 2005 Jun; 272(1):31-4. PubMed ID: 15480722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and management of pancreatic leaks after splenectomy with distal pancreatectomy performed during primary cytoreductive surgery for advanced ovarian, peritoneal and fallopian tube cancer.
    Kehoe SM; Eisenhauer EL; Abu-Rustum NR; Sonoda Y; D'Angelica M; Jarnagin WR; Barakat RR; Chi DS
    Gynecol Oncol; 2009 Mar; 112(3):496-500. PubMed ID: 19091388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer.
    Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Levine DA; Poynor EA; Aghajanian C; Jarnagin WR; DeMatteo RP; D'Angelica MI; Barakat RR; Chi DS
    Gynecol Oncol; 2006 Dec; 103(3):1083-90. PubMed ID: 16890277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns.
    Park JY; Seo SS; Kang S; Lee KB; Lim SY; Choi HS; Park SY
    Gynecol Oncol; 2006 Dec; 103(3):977-84. PubMed ID: 16837030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splenectomy during secondary cytoreductive surgery for epithelial ovarian cancer.
    Hanprasertpong J; Ohishi R; Iwasa N; Nagao S; Okamoto K; Fujiwara K
    Asian Pac J Cancer Prev; 2010; 11(2):413-6. PubMed ID: 20843126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between macroscopic and microscopic diseases on splenectomies performed in the surgical management of ovarian cancer.
    Uzan C; Bontoux LM; Gouy S; Duvillard P; Pautier P; Lhommé C; Morice P
    Int J Gynecol Cancer; 2010 Aug; 20(6):965-70. PubMed ID: 20683403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splenectomy during secondary cytoreduction for ovarian cancer disease recurrence: surgical and survival data.
    Manci N; Bellati F; Muzii L; Calcagno M; Alon SA; Pernice M; Angioli R; Panici PB
    Ann Surg Oncol; 2006 Dec; 13(12):1717-23. PubMed ID: 16957965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splenectomy in recurrent epithelial ovarian cancer.
    Gemignani ML; Chi DS; Gurin CC; Curtin JP; Barakat RR
    Gynecol Oncol; 1999 Mar; 72(3):407-10. PubMed ID: 10053114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splenectomy and surgical cytoreduction in epithelial ovarian cancer: a review.
    Hanprasertpong J; Fujiwara K
    Eur J Cancer Care (Engl); 2011 May; 20(3):287-93. PubMed ID: 20825460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anesthetic selection and disease-free survival following optimal primary cytoreductive surgery for stage III epithelial ovarian cancer.
    Elias KM; Kang S; Liu X; Horowitz NS; Berkowitz RS; Frendl G
    Ann Surg Oncol; 2015 Apr; 22(4):1341-8. PubMed ID: 25287437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splenectomy as part of cytoreductive surgery for ovarian carcinoma.
    Nicklin JL; Copeland LJ; O'Toole RV; Lewandowski GS; Vaccarello L; Havenar LP
    Gynecol Oncol; 1995 Aug; 58(2):244-7. PubMed ID: 7622112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splenectomy at the time of primary or interval cytoreductive surgery for epithelial ovarian carcinoma: A review of outcomes.
    Rush SK; Lees BF; Huang DS; Peterson MF; Al-Niaimi A
    Gynecol Oncol; 2022 Nov; 167(2):283-288. PubMed ID: 36114028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of splenic metastases on survival in FIGO stage IIIC epithelial ovarian cancer.
    Ayhan A; Al RA; Baykal C; Demirtas E; Ayhan A; Yüce K
    Int J Gynecol Cancer; 2004; 14(1):51-6. PubMed ID: 14764029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splenectomy as part of cytoreductive surgery in ovarian cancer.
    Magtibay PM; Adams PB; Silverman MB; Cha SS; Podratz KC
    Gynecol Oncol; 2006 Aug; 102(2):369-74. PubMed ID: 16631919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas.
    Chi DS; Zivanovic O; Levinson KL; Kolev V; Huh J; Dottino J; Gardner GJ; Leitao MM; Levine DA; Sonoda Y; Abu-Rustum NR; Brown CL; Barakat RR
    Gynecol Oncol; 2010 Oct; 119(1):38-42. PubMed ID: 20609464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary surgery or interval debulking for advanced epithelial ovarian cancer: does it matter?
    Markauskas A; Mogensen O; dePont Christensen R; Jensen PT
    Int J Gynecol Cancer; 2014 Oct; 24(8):1420-8. PubMed ID: 25180461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splenectomy and surgical cytoreduction for ovarian cancer.
    Chen LM; Leuchter RS; Lagasse LD; Karlan BY
    Gynecol Oncol; 2000 Jun; 77(3):362-8. PubMed ID: 10831343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Success rate and safety of tumor debulking with diaphragmatic surgery for advanced epithelial ovarian cancer and peritoneal cancer.
    Saitou M; Iida Y; Komazaki H; Narui C; Matsuno K; Kawabata A; Ueda K; Tanabe H; Takakura S; Isonishi S; Sasaki H; Okamoto A
    Arch Gynecol Obstet; 2015 Mar; 291(3):641-6. PubMed ID: 25182215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.